PROTEON THERAPEUTICS
Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).
PROTEON THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2001-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.proteontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
7818900102
Email Addresses:
[email protected]
Total Funding:
192.15 M USD
Technology used in webpage:
Domain Not Resolving GoDaddy DNS Digital Ocean
Similar Organizations
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Crossroads Rhode Island
Crossroads Rhode Island is to help homeless or at-risk individuals and families secure stable homes.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Optel Group
Optel Group is a provider of traceability systems for the pharmaceutical and medical device industries.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Renavance Pharma
Renavance Pharma, Inc. is a pharmaceutical company. Renavance Pharma, Inc. was incorporated in 2009 and is based in Mill Valley,
Reneo Pharmaceuticals
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-09-23 | Protara Therapeutics | Protara Therapeutics acquired by Proteon Therapeutics | N/A |
Investors List
Aqua Spark
Aqua Spark investment in Post-IPO Equity - Proteon Therapeutics
Seventure Partners
Seventure Partners investment in Post-IPO Equity - Proteon Therapeutics
Montis Capital
Montis Capital investment in Post-IPO Equity - Proteon Therapeutics
Nutreco
Nutreco investment in Post-IPO Equity - Proteon Therapeutics
PFR Life Science
PFR Life Science investment in Post-IPO Equity - Proteon Therapeutics
European regional development fund (ERDF)
European regional development fund (ERDF) investment in Grant - Proteon Therapeutics
Deerfield
Deerfield investment in Post-IPO Equity - Proteon Therapeutics
Inbio Ventures
Inbio Ventures investment in Series D - Proteon Therapeutics
Intersouth Partners
Intersouth Partners investment in Series D - Proteon Therapeutics
Deerfield
Deerfield investment in Series D - Proteon Therapeutics
Official Site Inspections
http://www.proteontherapeutics.com
- Host name: protara.wpmudev.host
- IP address: 104.156.225.247
- Location: Matawan United States
- Latitude: 40.4652
- Longitude: -74.2307
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07747
More informations about "Proteon Therapeutics"
Proteon Therapeutics - Wikipedia
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri. Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWor…See details»
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
Sep 23, 2019 Management and Organization The combined company will be led by Jesse Shefferman, ArTara Chief Executive Officer, and will be headquartered in New York, NY. The …See details»
Proteon Therapeutics Company Profile 2024: Valuation, Investors ...
Proteon Therapeutics is headquartered in Waltham, MA. What is the size of Proteon Therapeutics? Proteon Therapeutics has 17 total employees. What industry is Proteon …See details»
Proteon Therapeutics - Funding, Financials, Valuation & Investors
Sep 23, 2019 Proteon Therapeutics is registered under the ticker NASDAQ:PRTO . Proteon Therapeutics is funded by 19 investors. Aqua Spark and Seventure Partners are the most …See details»
Proteon Therapeutics - VentureRadar
Proteon Therapeutics, Inc (Waltham, MA and Kansas City, MO) is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the …See details»
Proteon Therapeutics Inc (PRTO) 10K Annual Reports & 10Q SEC …
Mar 13, 2019 Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, …See details»
Proteon Therapeutics - pharmstd-ventures.com
Proteon Therapeutics (NASDAQ:PRTO) Waltham, MA, USA Year of Investment: 2014. IPO in October, 2014 . Proteon Therapeutics Inc. is a biopharmaceutical company developing novel, …See details»
Organization | Proteon Therapeutics
Organization Overview. First Clinical Trial. 2008 NCT00679991. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Proteon Therapeutics, Inc Active Ingredients. …See details»
Proteon Therapeutics - Contacts, Employees, Board Members
Organization. Proteon Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and …See details»
Proteon Therapeutics to merge with ArTara Therapeutics
Proteon Therapeutics, which focuses on kidney and vascular diseases, has signed a definitive agreement to merge with rare and speciality disease drugs developer ArTara Therapeutics. …See details»
Proteon Therapeutics - Products, Competitors, Financials, …
Oct 22, 2014 Proteon Therapeutics is a company focused on the development of transformative therapies in the healthcare and biotechnology industry. The company's main offerings include …See details»
Proteon Therapeutics - Craft
Jan 9, 2020 Proteon Therapeutics is a late-stage biopharmaceutical company committed to improving the lives of patients and families affected by kidney and vascular diseases. The …See details»
Proteon Therapeutics Announces Review of Potential Strategic ...
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical …See details»
Proteon Therapeutics Appoints Paul Hastings Chairman of Its …
Oct 20, 2016 Proteon Therapeutics is committed to improving the health of patients with kidney and vascular diseases through the development of novel, first-in-class therapeutics. Proteon's …See details»
Proteon Therapeutics (PRTO) Stock Price, News & Analysis
Nov 22, 2024 Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular …See details»
Proteon sets out on its own after Novartis waves off a $550M deal
Mar 19, 2014 Five years after optioning the right to buy Proteon Therapeutics for up to $550 million, Novartis has walked away from the table despite what Proteon says was a successful …See details»
Protein therapeutics: a summary and pharmacological …
The number and frequency of use of protein therapeutics has increased dramatically since the introduction of the first recombinant protein therapeutic — human insulin — 25 years ago. …See details»
Livestock and Aquaculture Support | Proteon Pharmaceuticals
At Proteon Pharmaceuticals, we are shaping the future of farming and advancing animal health through innovative bacteriophage-based solutions.See details»
Proteon Therapeutics and ArTara Therapeutics Agree to
Sep 23, 2019 Management and Organization. The combined company will be led by Jesse Shefferman, ArTara Chief Executive Officer, and will be headquartered in New York, NY. The …See details»